Vertex Pharmaceuticals Overview

  • Founded
  • 1989
Founded
  • Status
  • Public
  • Employees
  • 3,000
Employees
  • Stock Symbol
  • VRTX
Stock Symbol
  • Investments
  • 12
  • Share Price
  • $207.15
  • (As of Monday Closing)

Vertex Pharmaceuticals General Information

Description

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 50 Northern Avenue
  • Boston, MA 02210
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vertex Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$207.15 $211.58 $192.32 - $306.08 $54B 260M 1.69M $8.02

Vertex Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 71,613,177 52,911,110 39,909,043 36,687,131
Revenue 5,402,685 4,162,821 3,047,597 2,488,652
EBITDA 2,345,539 1,496,684 706,780 103,258
Net Income 2,080,775 1,176,810 2,096,896 263,484
Total Assets 10,216,367 8,318,465 6,245,898 3,546,014
Total Debt 522,067 538,576 581,550 606,433
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vertex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vertex Pharmaceuticals‘s full profile, request access.

Request a free trial

Vertex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs
Drug Discovery
Boston, MA
3,000 As of 2019
00.000
0000 00.000

000 0000

ipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim v
0000000000000
High Point, NC
00 As of 0000
00000
00000000 00000

000 0000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000 000000000
South San Francisco, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vertex Pharmaceuticals Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
vTv Therapeutics Formerly PE-Backed High Point, NC 00 00000 00000000 00000
000 00000000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
000000000 00000000 Formerly VC-backed Zurich, Switzerland 000 00000 000000000 00000
0000000000 0000000 Formerly VC-backed Novato, CA 000 00000 00000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 37 competitors. Get the full list »

Vertex Pharmaceuticals Executive Team (32)

Name Title Board Seat Contact Info
Reshma Kewalramani MD Chief Executive Officer, President & Board Member
Charles Wagner Jr. Chief Financial Officer, Finance & Executive Vice President
Paul Silva Senior Vice President and Corporate Controller
Michael Parini Executive Vice President and Chief Administrative, Legal and Business Development Officer
Stephanie Franklin Chief Human Resources Officer & Senior Vice President
You’re viewing 5 of 32 executive team members. Get the full list »

Vertex Pharmaceuticals Board Members (18)

Name Representing Role Since
Alan Garber Ph.D Self Board Member and Member of Audit and Finance Committee and Scientific and Technology Committee 000 0000
Bruce Sachs Self Lead Independent Director and Chairman of Corporate Governance and Nominating Committee and Management Development and Compensation Committee 000 0000
Diana McKenzie Vertex Pharmaceuticals Board Member 000 0000
Jeffrey Leiden Ph.D Vertex Pharmaceuticals Executive Chairman 000 0000
Lloyd Carney Ph.D Vertex Pharmaceuticals Board Member and Member of Audit and Finance Committee 000 0000
You’re viewing 5 of 18 board members. Get the full list »

Vertex Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vertex Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vertex Pharmaceuticals‘s full profile, request access.

Request a free trial

Vertex Pharmaceuticals Investments & Acquisitions (12)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 11-Mar-2020 00000 00000 00 00000 Biotechnology
00000 000000000000 10-Oct-2019 000000000000000000 00000 Drug Discovery 0000000 000000 00.0
0000000 0000000000 16-Jul-2019 000000000000000000 00.000 Biotechnology
000000 00000000000 15-May-2019 000000000 0000 Biotechnology 0000000 000000 00.0
Genomics 30-Aug-2018 Early Stage VC 000.00 Drug Discovery 00000 000000000 00.0
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Vertex Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Drug Discovery Cambridge, MA 0000
To view Vertex Pharmaceuticals’s complete subsidiaries history, request access »

Vertex Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 07-Sep-2016 00000 00000 00 00000 Completed
  • 2 buyers
Altus Pharmaceuticals 06-Mar-2007 PIPE 0000 Completed
  • 3 buyers
To view Vertex Pharmaceuticals’s complete exits history, request access »